Search Results - Assaf Moore
- Showing 1 - 13 results of 13
-
1
-
2
Efficacy of immune‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis by Yulia Kundel, Michal Sternschuss, Assaf Moore, Gali Perl, Baruch Brenner, Hadar Goldvaser
Published in Cancer Medicine (2020-10-01)Get full text
Article -
3
-
4
The role of a radiopaque peri-rectal hydrogel spacer in aiding accurate daily image-guidance for prostate stereotactic radiotherapy by Oded Icht, Oded Icht, Shir Schlosser, Shir Schlosser, Miriam Weinstock-Sabbah, Mor Rephael, Dimitri Bragilovski, Assaf Moore, Assaf Moore, Tzippora Shochat, Dror Limon, Dror Limon, Elisha Fredman, Elisha Fredman
Published in Frontiers in Oncology (2024-06-01)Get full text
Article -
5
SABR-Dual: a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer by Elisha Fredman, Oded Icht, Assaf Moore, Dimitri Bragilovski, Jonathan Kindler, Shay Golan, Dror Limon
Published in BMC Cancer (2024-04-01)Get full text
Article -
6
Same-day versus delayed simulation imaging after placement of a perirectal hydrogel spacer for prostate radiotherapy by Elisha Fredman, Miriam Weinstock-Sabbah, Oded Icht, Assaf Moore, Tzippora Shochet, Dror Limon, Dimitri Bragilovski
Published in Frontiers in Oncology (2023-07-01)Get full text
Article -
7
The effect of gastric fundus radiation dose on postoperative anastomotic leakage in esophageal cancer by Yulia Kundel, Yulia Kundel, Noga Kurman, Omri Sulimani, Shlomo Gavrielli, Yuval Nachalon, Assaf Moore, Assaf Moore, Hanoch Kashtan, Hanoch Kashtan, Eyal Fenig, Eyal Fenig, Baruch Brenner, Baruch Brenner, Aron Popovtzer, Aron Popovtzer, Elisha Fredman, Elisha Fredman
Published in Frontiers in Oncology (2023-02-01)Get full text
Article -
8
The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real‐world early‐stage breast cancer by Daniel A. Goldstein, Chen Mayer, Tzippy Shochat, Daniel Reinhorn, Assaf Moore, Michal Sarfaty, Rinat Yerushalmi, Hadar Goldvaser
Published in Cancer Medicine (2020-07-01)Get full text
Article -
9
-
10
Early PET‐CT in patients with pathological stage III colon cancer may improve their outcome: Results from a large retrospective study by Assaf Moore, Olga Ulitsky, Irit Ben‐Aharon, Gali Perl, Yulia Kundel, Michal Sarfaty, Ron Lewin, Liran Domachevsky, Hanna Bernstine, David Groshar, Nir Wasserberg, Hanoch Kashtan, Noa Gordon, Aaron Sulkes, Baruch Brenner
Published in Cancer Medicine (2018-11-01)Get full text
Article -
11
Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma by Assaf Moore, Michal Cohen-Naftaly, Anna Tobar, Yulia Kundel, Ofer Benjaminov, Marius Braun, Assaf Issachar, Eytan Mor, Michal Sarfaty, Dimitri Bragilovski, Ran Ben Hur, Noa Gordon, Salomon M. Stemmer, Aaron M. Allen
Published in Radiation Oncology (2017-10-01)Get full text
Article -
12
Hypofractionated Radiation Therapy (Hypo-RT) for the Treatment of Localized Bladder Cancer by Assaf Moore, Stephanie M. Lobaugh, Zhigang Zhang, Jonathan E. Rosenberg, Gopa Iyer, Min Yuen Teo, Bernard Bochner, Timothy Donahue, David Aramburu Nunez, Alexandra Dreyfuss, Daniel Gorovets, Michael J. Zelefsky, Marisa A. Kollmeier
Published in Bladder Cancer (2023-06-01)Get full text
Article -
13
First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma – A real-world experience from Israel by Itamar Averbuch, Saeed Salman, Saeed Salman, Noa Shtamper, Ilana Doweck, Ilana Doweck, Aron Popovtzer, Gal Markel, Daniel Hendler, Inbar Finkel, Assaf Moore, Eyal Fenig, Tarek Taha, Kamel Mhameed, Noga Kurman, Salem Billan, Salem Billan
Published in Frontiers in Oncology (2023-01-01)Get full text
Article
